Tumor immunogenicity depends on tumor-associated antigens (TAA) presented on MHC class I molecules, recognized by CD8+ cells that trigger apoptosis, cell cycle arrest, and the release of anti-tumor mediators like IFN-γ and TNF-α [84]. Here, CD8A is linked to neoplasm.